The perinatal infection of cytomegalovirus is an important etiology for biliary atresia in China

Clinical Pediatrics

Volumn 51, Issue 2, 2012, Pages 109-113

  Xu, Yi ^a   Yu, Jiakang ^a   Zhang, Ruizhong ^a   Yin, Yingxian ^a   Ye, Jiawei ^a   Tan, Limei ^a   Xia, Huimin ^a  

^a Guangzhou Women and Children's Medical Centre   (China)

Author keywords

biliary atresia; cytomegalovirus; perinatal

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; VIRUS DNA; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; BILE DUCT ATRESIA; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; DNA EXTRACTION; ENDOTHELIUM CELL; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE ANALYSIS; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INFANT; INFECTION RATE; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PORTOENTEROSTOMY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TARGET CELL; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS STRAIN;

BILE DUCTS, INTRAHEPATIC; BILIARY ATRESIA; CELLS, CULTURED; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA VIRUS INFECTIONS; EPITHELIAL CELLS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER; MALE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84863069970     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922811406264     Document Type: Article

References (23)

1. Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis. 2001 ; 21: 517-524 (Pubitemid 33131043)
2. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation". Hepatology. 1992 ; 16: 1069-1083
3. Kelly DA, Davenport M. Current management of biliary atresia. Arch Dis Child. 2007 ; 92: 1132-1135 (Pubitemid 350221462)
4. Wong KK, Chung PH, Chan IH, Lan LC, Tam PK. Performing Kasai portoenterostomy beyond 60 days of life is not necessarily associated with a worse outcome. J Pediatr Gastroenterol Nutr. 2010 ; 51: 631-634
5. Johnson KN, Koontz CS, Ricketts RR. Role of hepatic portocholecystostomy ('gallbladder Kasai') in treating infants with biliary atresia. Am Surg. 2010 ; 76: 883-887
6. Balistreri WF. Pediatric hepatology. A half-century of progress. Clin Liver Dis. 2000 ; 4: 191-210
7. Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J Pediatr Gastroenterol Nutr. 2006 ; 42: 77-82 (Pubitemid 43061014)
8. Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst-the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg. 1974 ; 6: 113-139
9. Rauschenfels S, Krassmann M, Al-Masri AN, et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr. 2009 ; 168: 469-476
10. Davenport M, De Ville de, Goyet J, Stringer MD, et al. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet. 2004 ; 363: 1354-1357 (Pubitemid 38529874)
11. Schreiber RA, Barker CC, Roberts EA, et al. Canadian Pediatric Hepatology Research Group. Biliary atresia: the Canadian experience. J Pediatr. 2007 ; 151: 659-665
12. Wada H, Muraji T, Yokoi A, et al. Insignificant seasonal and geographical variation in incidence of biliary atresia in Japan: a regional survey of over 20 years. J Pediatr Surg. 2007 ; 42: 2090-2092 (Pubitemid 350235513)
13. Wiederkehr JC, Coelho IM, Avilla SG, et al. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc. 2010 ; 42: 521-522
14. Yang H, Plösch T, Lisman T, et al. Inflammation mediated down-regulation of hepatobiliary transporters contributes to intrahepatic cholestasis and liver damage in murine biliary atresia. Pediatr Res. 2009 ; 66: 380-385
15. Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. Herpes. 2004 ; 11: 77-86 (Pubitemid 40064892)
16. Razonable RR, Paya CV. Herpes virus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003 ; 10: 60-65 (Pubitemid 38076249)
17. Kourí V, Correa CB, Verdasquera D, et al. Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis J. 2010 ; 29: 1105-1110
18. De Paschale M, Agrappi C, Manco MT, Clerici P. Positive predictive value of anti-HCMV IgM as an index of primary infection. J Virol Methods. 2010 ; 168: 121-125
19. Kepler GM, Banks HT, Davidian M, Rosenberg ES. A model for HCMV infection in immunosuppressed patients. Math Comput Model. 2009 ; 49: 1653-1663
20. De Tommaso AM, Andrade PD, Costa SC, Escanhoela CA, Hessel G. High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. BMC Infect Dis. 2005 ; 5: 108
21. Yi X, Feng F, Xiang Z, Ge L. The effects of allitridin on the expression of transcription factors T-bet and GATA-3 in mice infected by murine cytomegalovirus. J Med Food. 2005 ; 8: 332-336 (Pubitemid 41502415)
22. Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002 ; 360: 1563-1659
23. Davenport M, Gonde C, Redkar R, et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg. 2001 ; 36: 1017-1025 (Pubitemid 32619749)